We are live on ! Find out more
IMVT icon

Immunovant
IMVT

215 hedge funds and large institutions have $2.75B invested in Immunovant in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 40 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

619% more call options, than puts

Call options by funds: $61.3M | Put options by funds: $8.52M

133% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 40

92% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 24

10% more funds holding

Funds holding: 196 → 215 (+19)

1% less capital invested

Capital invested by funds: $2.76B → $2.75B (-$14.3M)

7.63% less ownership

Funds ownership: 61.96% → 54.34% (-7.6%)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
215
Holders Change
+19
Holders Change %
+9.69%
% of All Funds
2.65%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
46
Increased
93
Reduced
40
Closed
24
Calls
$61.3M
Puts
$8.52M
Net Calls
+$52.8M
Net Calls Change
+$26.3M

Top Buyers

1
TCM
TCG Crossover Management
California
+$72.4M
2
Jennison Associates
Jennison Associates
New York
+$64.6M
3
FCM
Farallon Capital Management
California
+$39.7M
4
State Street
State Street
Massachusetts
+$19.4M
5
Bank of America
Bank of America
North Carolina
+$15M

Top Sellers

1
AC
Armistice Capital
New York
-$56.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$50.8M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$37.5M
4
Morgan Stanley
Morgan Stanley
New York
-$25.1M
5
SCM
Soleus Capital Management
Connecticut
-$22.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
KK
126
KLP Kapitalforvaltning
Norway
$469K – – –
MAM
127
Martingale Asset Management
Massachusetts
$462K +$482K +18,607 New
SEI Investments
128
SEI Investments
Pennsylvania
$441K +$128K +4,962 +39%
EFM
129
E Fund Management
China
$440K +$459K +17,715 New
Nomura Holdings
130
Nomura Holdings
Japan
$398K +$415K +16,011 New
MG
131
Marex Group
$397K +$414K +16,000 New
State Board of Administration of Florida Retirement System
132
State Board of Administration of Florida Retirement System
Florida
$392K – – –
TRCT
133
Tower Research Capital (TRC)
New York
$370K +$294K +11,353 +320%
Barclays
134
Barclays
United Kingdom
$370K -$5.63M -217,426 -94%
EF
135
Empowered Funds
Pennsylvania
$362K +$9.86K +381 +3%
DFCM
136
Dark Forest Capital Management
Puerto Rico
$353K +$3.42K +132 +0.9%
KAS
137
Kestra Advisory Services
Texas
$346K +$128K +4,936 +55%
KeyBank National Association
138
KeyBank National Association
Ohio
$342K +$357K +13,784 New
Allianz Asset Management
139
Allianz Asset Management
Germany
$320K – – –
Prudential Financial
140
Prudential Financial
New Jersey
$318K +$331K +12,800 New
OAM
141
Oxford Asset Management
United Kingdom
$309K +$322K +12,456 New
GC
142
Guggenheim Capital
Illinois
$308K +$3.16K +122 +1%
Mirae Asset Global Investments
143
Mirae Asset Global Investments
South Korea
$264K +$54.3K +2,099 +25%
Canada Life
144
Canada Life
Manitoba, Canada
$259K +$113K +4,373 +73%
Teacher Retirement System of Texas
145
Teacher Retirement System of Texas
Texas
$258K +$4.66K +180 +2%
VIA
146
Virtus Investment Advisers
Connecticut
$256K +$6.5K +251 +2%
Victory Capital Management
147
Victory Capital Management
Texas
$239K +$27.9K +1,077 +13%
VA
148
Vident Advisory
Georgia
$224K +$233K +9,011 New
PEAK6
149
PEAK6
Illinois
$216K +$225K +8,709 New
EGM
150
Engineers Gate Manager
New York
$215K +$224K +8,660 New
4 5
6
7 8

IMVT Hedge Fund Activity: Q1 2026 in Review

215 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2026, worth a combined $2.75B — down 0.52% from $2.76B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IMVT positions and 24 closed out — a net gain of 22 holders — while 93 added to existing stakes and 40 trimmed.

The largest buyer was TCG Crossover Management, adding an estimated $72.4M. The largest seller was Armistice Capital, cutting an estimated $56.5M.

  • 215 institutional investors held Immunovant (IMVT) as of Q1 2026, up from 196 in Q4 2025.
  • Funds reported $2.75B of Immunovant stock for Q1 2026, down 0.52% quarter-over-quarter.
  • 46 funds opened new Immunovant positions in Q1 2026 and 24 closed out, a net change of +22 holders.
  • The largest Immunovant buyer in Q1 2026 was TCG Crossover Management, an estimated $72.4M added.
  • The largest Immunovant seller in Q1 2026 was Armistice Capital, an estimated $56.5M sold.

Based on aggregated 13F filings for Q1 2026.